Table 2.

Inhibition of HSV-1-related CPE by using different concentrations of the most potent tested compounds and a standard drug (ACV).

Concentration (μg/mL)	Compound 4	Compound 6	Compound 8	ACV
	CPE Inhibition (%) Mean ± SE
6	0.00 ± 0.00	0.00 ± 0.00	0.00 ± 0.00	0.00 ± 0.00
12	14.25 ± 3.75	30.30 ± 3.40	31.95 ± 2.75	29.00 ± 3.00
18	22.35 ± 2.25	45.90 ± 3.40	41.25 ± 4.05	49.80 ± 3.40
24	42.35 ± 1.85	65.15 ± 1.75	72.25 ± 2.05	70.45 ± 2.75
32	62.00 ± 5.00	80.40 ± 10.00	80.00 ± 10.00	77.65 ± 1.75
36	75.75 ± 9.85	99.00 ± 1.00	99.00 ± 1.00	92.50 ± 4.50
42	99.50 ± 0.50			99.50 ± 0.50